These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6985835)

  • 1. Chemoimmunotherapy with Corynebacterium parvum in acute myelocytic leukemia.
    Eppinger-Helft M; Pavlovsky S; Hidalgo G; Muriel FS; Suárez A; Garay G; Russo C; Santos M; Macchi A; Lein J
    Cancer; 1980 Jan; 45(2):280-4. PubMed ID: 6985835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
    Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
    Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.
    Hayat M; Jehn U; Willemze R; Haanen C; Zittoun R; Monconduit M; Lowenberg B; Stryckmans P; Peetermans M; De Cataldo F
    Cancer; 1986 Aug; 58(3):617-23. PubMed ID: 3524789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential therapy for induction and maintenance of remission in acute myeloblastic leukemia.
    Eppinger-Helft M; Pavlovsky S; Suarez A; Muriel FS; Hidalgo G; Pavlovsky A; Vilaseca G
    Cancer; 1975 Feb; 35(2):347-53. PubMed ID: 1053936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoimmunotherapy in acute myelocytic leukemia.
    Holland JF; Bekesi JG; Cuttner J; Glidewell O
    Isr J Med Sci; 1977 Jul; 13(7):694-700. PubMed ID: 270473
    [No Abstract]   [Full Text] [Related]  

  • 6. Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocyte leukemia: a randomized collaborative study.
    Mandelli F; De Lipsis E; Grignani F; Martelli M; Liso V; Amadori S
    Med Pediatr Oncol; 1978; 4(3):231-40. PubMed ID: 277749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood acute lymphocytic leukemia: study VIII.
    Aur RJ; Simone JV; Verzosa MS; Hustu HO; Barker LF; Pinkel DP; Rivera G; Dahl GV; Wood A; Stagner S; Mason C
    Cancer; 1978 Nov; 42(5):2123-34. PubMed ID: 363252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of acute lymphoblastic leukemia in children.
    Haghbin M
    Am J Hematol; 1976; 1(2):201-9. PubMed ID: 1069475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in the treatment of acute myeloid leukemia in children. Experience of the Argentinian Group of Acute Leukemia Treatment and the Latin American Group of Malignant Hemopathies Treatment 1967-1987].
    Freigeiro D; Scaglione C; Santarelli MT; Sackmann Muriel F; Jiménez E; Pavlovsky S; Bustelo P; Richard L; Kohan R; Kvicala R
    Sangre (Barc); 1989 Jun; 34(3):221-8. PubMed ID: 2669186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoimmunotherapy of adult acute leukemia.
    McCredie KB; Bodey GP; Freireich EJ; Hester JP; Rodriguez V; Keating MJ
    Cancer; 1981 Mar; 47(6):1256-61. PubMed ID: 6939477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenance.
    Morrison FS; Kopecky KJ; Head DR; Athens JW; Balcerzak SP; Gumbart C; Dabich L; Costanzi JJ; Coltman CA; Saiki JH
    Leukemia; 1992 Jul; 6(7):708-14. PubMed ID: 1625490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable response to maintenance therapy of second or subsequent remissions in childhood acute lymphocytic leukemia.
    Kimball JC; Herson J; Sullivan MP
    Cancer; 1980 Sep; 46(5):1093-7. PubMed ID: 6938300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone.
    Gingrich RD; Armitage JO; Burns CP
    Cancer Treat Rep; 1978 Sep; 62(9):1389-91. PubMed ID: 356988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia.
    Wiernik PH; Glidewell OJ; Hoagland HC; Brunner KW; Spurr CL; Cuttner J; Silver RT; Carey RW; DelDuca V; Kung FH; Holland JF
    Med Pediatr Oncol; 1979; 6(3):261-77. PubMed ID: 381887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of intermittent alternating drug program reinduction therapy on the frequency and duration of response in adult acute leukemia.
    McCredie KB; Freireich EJ; Bodey GP; Burgess MA; Whitecar JP; Smith TL
    Med Pediatr Oncol; 1976; 2(3):309-18. PubMed ID: 979915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The definitive treatment of children with acute leukemia.
    Walters TR
    Med Clin North Am; 1976 Sep; 60(5):987-1000. PubMed ID: 781418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
    Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.
    Rees JK; Gray RG; Swirsky D; Hayhoe FG
    Lancet; 1986 Nov; 2(8518):1236-41. PubMed ID: 2878130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.